COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,870 Articles (22,568 medRxiv, 8,302 bioRxiv)

Most recent first Previous |  Page 1133: Articles 11321-11330  | Next

Public awareness and support for use of wastewater for SARS-CoV-2 monitoring: A community survey in Louisville, Kentucky
Holm, R. H., Brick, J. M., Amraotkar, A. R., Hart, J. L., Mukherjee, A., Zeigler, J., Bushau-Sprinkle, A. M., Anderson, L. B., Walker, K. L., Talley, D., Keith, R., Rai, S., Palmer, K. E., Bhatnagar, A., Smith, T. R.
10.1101/2021.10.19.21264954 — Posted: 2021-10-22
Symptoms compatible with long-COVID in healthcare workers with and without SARS-CoV-2 infection - results of a prospective multicenter cohort
Strahm, C., Seneghini, M., Guesewell, S., Egger, T., Leal-Neto, O., Brucher, A., Lemmenmaier, E., Meier Kleeb, D., Moeller, C., Rieder, P., Ruetti, M., Rutz, R., Schmid, H.-R., Stocker, R., Vuichard-Gysin, D., Wiggli, B., Besold, U., Kuster, S. P., McGeer, A., Risch, L., Friedl, A., Schlegel, M., Schmid, D., Vernazza, P., Kahlert, C. R., Kohler, P.
10.1101/2021.10.19.21265187 — Posted: 2021-10-22
Can the Rapid Antigen Test for COVID-19 Replace RT-PCR: A Meta-analysis of Test Agreement
Elmakaty, I. M., Elsayed, A. A., Hommos, R. G., Abdo, R. S., Mohamed, A. G., Yousif, Z. B., Fakhroo, M. M., Alansari, A. A., Coyle, P. V., Doi, S. A. R.
10.1101/2021.10.19.21265190 — Posted: 2021-10-22
Use and impact of virtual primary care on quality and safety: public perspectives during the COVID-19 pandemic
Neves, A. L., Dael, J. v., O'Brien, N., Flott, K., Ghafur, S., Darzi, A., Mayer, E.
10.1101/2021.10.19.21265193 — Posted: 2021-10-22
Psychological distress of healthcare workers in Quebec (Canada) during the second and the third pandemic waves
Carazo, S., Pelletier, M., Talbot, D., Jauvin, N., De Serres, G., Vezina, M.
10.1101/2021.10.19.21265175 — Posted: 2021-10-22
General Practitioner perspectives and wellbeing during the COVID-19 Pandemic: a mixed method social media analysis
Golder, S., Jefferson, L., McHugh, E., Essex, H., Heathcote, C., Castro-Avila, A. C., Dale, V., Van Der Feltz-Cornelis, C., Bloor, K.
10.1101/2021.10.19.21265194 — Posted: 2021-10-22
Immunogenicity and reactogenicity of booster vaccinations after Ad26.COV2.S priming
Sablerolles, R., Rietdijk, W., Goorhuis, B., Postma, D., Visser, L., Geers, D., Schmitz, K., Garcia Garrido, H., Koopmans, M., Dalm, V., Kootstra, N. A., Huckriede, A., Lafeber, M., van Baarle, D., GeurtsvanKessel, C., de Vries, R. D., van der Kuy, H., SWITCH research group
10.1101/2021.10.18.21264979 — Posted: 2021-10-22
REACT-1 study round 14: High and increasing prevalence of SARS-CoV-2 infection among school-aged children during September 2021 and vaccine effectiveness against infection in England
Chadeau-Hyam, M., Wang, H., Eales, O., Haw, D. J., Bodinier, B., Whitaker, M., Walters, C. E., Ainslie, K. E. C., Atchison, C. J., Fronterre, C., Diggle, P. J., Page, A., Trotter, A., Ashby, D., Barclay, W., Taylor, G. P., Cooke, G., Ward, H., Darzi, A., Riley, S., Donnelly, C. A., Elliott, P.
10.1101/2021.10.14.21264965 — Posted: 2021-10-22
Who has long-COVID? A big data approach
Pfaff, E. R., Girvin, A. T., Bennett, T. D., Bhatia, A., Brooks, I. M., Deer, R. R., Dekermanjian, J. P., Jolley, S. E., Kahn, M. G., McMurry, J. A., Moffitt, R. A., Walden, A., Chute, C. G., Haendel, M. A., The N3C Consortium
10.1101/2021.10.18.21265168 — Posted: 2021-10-22
COVID-19: Knowledge, Perception of Risk, Preparedness and Vaccine Acceptability among Healthcare Workers in Kenya
Abdulle, H. M., Masika, M. M., Oyugi, J. O.
10.1101/2021.10.19.21264712 — Posted: 2021-10-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).